https://soundcloud.com/proqr
Stream ProQR Therapeutics | Listen to podcast episodes online for free on SoundCloud
Play ProQR Therapeutics and discover followers on SoundCloud | Stream tracks, albums, playlists on desktop and mobile.
podcast episodes onlinestreamproqrtherapeuticslisten
https://www.proqr.com/press-releases/proqr-announces-planned-changes-to-board-composition
ProQR Announces Planned Changes to Board Composition | ProQR Therapeutics
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
announces plannedproqrchangesboardcomposition
https://www.proqr.com/founding-story
ProQR Therapeutics – Founded on a personal mission to help patients
When our CEO, Daniel A. de Boer, knew his newborn son had an incurable rare disease, he founded ProQR to help people like his son. Learn more.
proqrtherapeuticsfoundedpersonalmission
https://www.proqr.com/press-releases?f%5B0%5D=year%3A2024
SEO page - Press releases overview | ProQR Therapeutics
press releases overviewseoproqrtherapeutics
https://www.biopharmadive.com/news/proqr-restructure-workforce-layoffs-sepofarsen-failure/629448/
Shifting focus, ProQR to seek partners for stalled eye drugs | BioPharma Dive
The company will wind down five trials involving two drug candidates and lay off more staff, prioritizing instead its RNA-editing technology.
shifting focusproqrseekpartnersstalled
https://www.proqr.com/science/axiomer-technology/axiomer-technology-explained
How does Axiomer RNA editing work | ProQR Therapeutics
What is RNA and how can we use the body's own RNA editing machinery to treat disease? Learn more about the Axiomer® RNA editing technology and how we are...
rna editingworkproqrtherapeutics
https://www.proqr.com/press-releases/proqr-announces-upcoming-presentation-at-rna-editing-summit
ProQR Announces Upcoming Presentation at RNA Editing Summit | ProQR Therapeutics
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
announces upcomingrna editingproqrpresentationsummit
https://www.proqr.com/press-releases?f%5B0%5D=year%3A2015
SEO page - Press releases overview | ProQR Therapeutics
press releases overviewseoproqrtherapeutics
https://www.proqr.com/press-releases
SEO page - Press releases overview | ProQR Therapeutics
press releases overviewseoproqrtherapeutics
https://www.proqr.com/press-releases?f%5B0%5D=year%3A2018
SEO page - Press releases overview | ProQR Therapeutics
press releases overviewseoproqrtherapeutics
https://www.proqr.com/press-releases?page=0
SEO page - Press releases overview | ProQR Therapeutics
press releases overviewseoproqrtherapeutics
https://www.proqr.com/press-releases?f%5B0%5D=year%3A2020
SEO page - Press releases overview | ProQR Therapeutics
press releases overviewseoproqrtherapeutics
https://www.proqr.com/press-releases?f%5B0%5D=year%3A2023
SEO page - Press releases overview | ProQR Therapeutics
press releases overviewseoproqrtherapeutics
https://www.proqr.com/community-stories-and-news/proqr-recognised-as-a-great-place-to-work
ProQR recognised as a Great Place To Work | ProQR Therapeutics
In April 2025, ProQR received the Great Place To Work (GPTW) certification following the results of the employee survey from GPTW Netherlands.
great placeproqrrecognisedworktherapeutics
https://www.proqr.com/investors-media/proqr-corporate-presentation
ProQR corporate presentation | ProQR Therapeutics
Download the latest ProQR corporate presentation (PDF).
corporate presentationproqrtherapeutics
https://www.proqr.com/press-releases/proqr-announces-first-quarter-2025-operating-and-financial-results
ProQR Announces First Quarter 2025 Operating and Financial Results | ProQR Therapeutics
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
announces first quarterfinancial resultsproqroperatingtherapeutics
https://www.proqr.com/press-releases/proqr-to-host-virtual-investor-and-analyst-event-highlighting-pipeline-on-april-8-2026
ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026 | ProQR...
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
proqrhostvirtualinvestoranalyst
https://www.proqr.com/press-releases/proqr-announces-annual-general-meeting-of-shareholders-to-be-held-june-3-2025
ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025 | ProQR Therapeutics
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
annual general meetingproqrannouncesshareholdersheld
https://www.proqr.com/press-releases/proqr-announces-upcoming-scientific-presentations-at-asgct-and-tides-conferences
ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences | ProQR...
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
announces upcomingproqrscientificpresentationstides
https://www.proqr.com/
ProQR Therapeutics - Creating RNA therapies for patients in need
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
proqrtherapeuticscreatingrnatherapies
https://www.proqr.com/press-releases/proqr-therapeutics-to-host-virtual-analyst-and-investor-event-on-december-11-2024
ProQR Therapeutics to Host Virtual Analyst and Investor Event on December 11, 2024 | ProQR...
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
investor eventproqrtherapeuticshostvirtual
https://www.proqr.com/leadership
ProQR leadership – An experienced team of healthcare specialists
ProQR's leadership is a strong team with proven track record. Find out who is on our management team, board of directors and scientific advisory board.
proqrleadershipexperiencedteamhealthcare
https://www.proqr.com/ProQRian-profiles
ProQRian Profiles | ProQR Therapeutics
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
profilesproqrtherapeutics
https://www.proqr.com/press-releases?page=2
SEO page - Press releases overview | ProQR Therapeutics
press releases overviewseoproqrtherapeutics
https://www.proqr.com/press-releases/proqr-announces-cta-submission-for-phase-1-study-of-ax-0810-targeting-ntcp
ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP | ProQR Therapeutics
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
proqrannouncesctasubmissionphase
https://www.proqr.com/about-proqr-therapeutics
About ProQR Therapeutics – Patient-focused drug development
An innovative biotech company advancing our proprietary Axiomer RNA-editing platform technology.
patient focusedproqrtherapeuticsdrugdevelopment
https://www.proqr.com/press-releases/proqr-strengthens-leadership-with-appointments-of-cfo-and-cmo-to-support-next-phase-of-growth
ProQR Strengthens Leadership with Appointments of CFO and CMO to Support Next Phase of Growth |...
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
strengthens leadershipnext phaseproqrappointmentscfo
https://www.proqr.com/partnerships
Partnerships | ProQR Therapeutics
ProQR has collaborations with important names in the industry including Eli Lilly and Company. Read more about our partnerships.
partnershipsproqrtherapeutics
https://www.proqr.com/press-releases/proqr-to-participate-in-upcoming-investor-conferences-in-october-2025
ProQR to Participate in Upcoming Investor Conferences in October 2025 | ProQR Therapeutics
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
proqrparticipateupcominginvestorconferences
https://www.proqr.com/disclaimer
Disclaimer | ProQR Therapeutics
This website contains forward-looking statements about potential therapeutic uses and effects of ProQR Therapeutics’ products, including but not limited to our...
disclaimerproqrtherapeutics
https://www.proqr.com/events
SEO page - Events overview | ProQR Therapeutics
events overviewseoproqrtherapeutics
https://www.europharmajobs.com/jobs_at/proqr_therapeutics/12150
Jobs at ProQR Therapeutics | EuroPharmaJobs
Pharma Jobs at ProQR Therapeutics in Europe from EuroPharmaJobs.
jobsproqrtherapeutics
https://www.proqr.com/investors-and-media
Investors & Media | ProQR Therapeutics
Located in Leiden, Netherlands and Cambridge, Mass., ProQR Therapeutics (Nasdaq:PRQR) is a clinical-stage biotechnology company developing RNA therapies for...
investorsmediaproqrtherapeutics
https://www.proqr.com/investors-media/financials-and-filings
ProQR Therapeutics (Nasdaq: $PRQR) – Financial Information
Find all financial information on ProQR including SEC filings, annual reports and all documents for shareholder meetings.
proqrtherapeuticsnasdaqfinancialinformation
https://www.proqr.com/press-releases?page=11
SEO page - Press releases overview | ProQR Therapeutics
press releases overviewseoproqrtherapeutics
https://www.proqr.com/press-releases/proqr-announces-webcast-of-presentation-at-the-2026-citizens-life-sciences-conference
ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference | ProQR...
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
life sciencesproqrannounceswebcastpresentation
https://www.proqr.com/pipeline/ax-0810-cholestatic-diseases-ntcp/biliary-atresia
Biliary atresia | ProQR Therapeutics
This page provides information about biliary atresia, its symptoms, causes and what treatment options are available.
biliaryproqrtherapeutics
https://www.proqr.com/press-releases?f%5B0%5D=year%3A2026
SEO page - Press releases overview | ProQR Therapeutics
press releases overviewseoproqrtherapeutics
https://www.proqr.com/press-releases/proqr-announces-webcast-of-presentation-at-the-2025-citizens-life-sciences-conference
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference | ProQR...
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
life sciencesproqrannounceswebcastpresentation
https://www.proqr.com/press-releases/proqr-announces-year-end-2024-operating-and-financial-results
ProQR Announces Year End 2024 Operating and Financial Results | ProQR Therapeutics
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
year endfinancial resultsproqrannouncesoperating
https://www.proqr.com/press-releases/proqr-announces-encouraging-ax-0810-phase-1-safety-and-pk-data-development-candidate-selections-and-2026-outlook
ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections,...
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
data developmentproqrannouncesencouragingax
https://www.proqr.com/science
Science | ProQR Therapeutics
At ProQR science is literally at the heart of what we do. Our passion lies in discovering the latest RNA technologies and translating them to life-changing...
scienceproqrtherapeutics
https://www.proqr.com/community-stories-and-news
SEO page - Blog overview | ProQR Therapeutics
blog overviewseoproqrtherapeutics
https://www.proqr.com/press-releases?f%5B0%5D=year%3A2017
SEO page - Press releases overview | ProQR Therapeutics
press releases overviewseoproqrtherapeutics
https://www.proqr.com/press-releases/email-alerts
ProQR Therapeutics (Nasdaq: $PRQR) – Press release email alerts
Receive an email notification whenever ProQR issues a new press release. Never miss an important update again. Sign up now!
press releaseproqrtherapeuticsnasdaqemail
https://www.proqr.com/press-releases/proqr-announces-second-quarter-2025-operating-and-financial-results
ProQR Announces Second Quarter 2025 Operating and Financial Results | ProQR Therapeutics
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
announces secondfinancial resultsproqrquarteroperating
https://www.proqr.com/press-releases/proqr-announces-year-end-2025-operating-and-financial-results
ProQR Announces Year End 2025 Operating and Financial Results | ProQR Therapeutics
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
year endfinancial resultsproqrannouncesoperating
https://www.proqr.com/investors-media/stock-info
Stock info | ProQR TherapeuticsProQR Therapeutics (Nasdaq: $PRQR) – Share price information
Find out how ProQR’s stock is trading now and in the past. Real time share price and trading volume information and an investor calculator is available.Find...
share pricestockinfoproqrtherapeutics
https://www.proqr.com/pipeline
Pipeline | ProQR Therapeutics
ProQR is pioneering a next-generation RNA technology called Axiomer™, which uses a cell’s own editing machinery called ADAR to make specific single nucleotide...
pipelineproqrtherapeutics
https://www.proqr.com/press-releases/proqr-therapeutics-announces-81-million-in-new-funding-from-rett-syndrome-research-trust-to-expand-rna-editing-collaboration
ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to...
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
therapeutics announcesnew fundingrett syndromeresearch trustproqr
https://www.proqr.com/press-releases/proqr-highlights-pipeline-expansion-and-multiple-upcoming-clinical-catalysts-at-investor-and-analyst-event
ProQR Highlights Pipeline Expansion and Multiple Upcoming Clinical Catalysts at Investor and...
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
pipeline expansionproqrhighlightsmultipleupcoming
https://www.proqr.com/press-releases?f%5B0%5D=year%3A2016
SEO page - Press releases overview | ProQR Therapeutics
press releases overviewseoproqrtherapeutics
https://www.proqr.com/careers
Careers at ProQR Therapeutics
At our offices in Leiden we are advancing our proprietary Axiomer RNA-editing platform technology. Our ProQRians, representing over 30 nationalities, are...
careersproqrtherapeutics
https://www.proqr.com/press-releases/proqr-announces-annual-general-meeting-of-shareholders-to-be-held-june-2-2026
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026 | ProQR Therapeutics
ProQR is a biotech company that discovers and develops unique RNA therapies for severe rare and common diseases, based in Leiden, The Netherlands.
annual general meetingproqrannouncesshareholdersheld